Related Experiment Video
Updated: Jan 27, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Percutaneous Left Atrial Appendage Closure in Patients With Cardioembolic Stroke Despite Oral Anticoagulant Therapy:
Alberto Preda1, Claudio Montalto2, Luigi De Luca3
1De Gasperis Cardio Center, Electrophysiology Unit, Niguarda Hospital, Milan, Italy.
Insights
Left atrial appendage closure (LAAC) combined with oral anticoagulation (OAC) offers better outcomes for atrial fibrillation patients experiencing cardioembolic stroke (CS) despite OAC. This hybrid strategy significantly reduces stroke recurrence compared to OAC alone.
Area of Science:
- Cardiology
- Interventional Cardiology
- Stroke Medicine
Background:
- Atrial fibrillation (AF) patients with prior cardioembolic stroke (CS) despite adequate oral anticoagulation (OAC) present a clinical challenge.
- Left atrial appendage closure (LAAC) is a potential intervention for these high-risk individuals.
Purpose of the Study:
- To evaluate the safety and efficacy of a hybrid strategy combining LAAC and continued OAC in patients with OAC failure.
- To compare outcomes of this hybrid strategy against medical therapy (MT) alone in patients with CS despite adequate OAC.
Main Methods:
- A multicenter study comparing patients who underwent LAAC plus OAC versus MT alone after an index CS event while on adequate OAC.
- Exclusion of other embolic sources and continuation of OAC for all participants.
- Primary endpoint: composite of all-cause death, CS, and major bleeding.
Main Results:
- The LAAC group (44 patients) showed a significantly lower rate of the primary endpoint (HR 0.398, p=0.008) and CS recurrence (HR 0.273, p=0.041) compared to the MT group (65 patients) at 48 months follow-up.
- Annualized CS rate was 2.0 per 100 patient-years in the LAAC group versus 7.8 per 100 patient-years in the MT group.
- CHA2DS2VA, NIHSS, and acute reperfusion therapy predicted the primary endpoint; CHA2DS2VA and NIHSS predicted CS recurrence. Propensity-score matching confirmed results.
Conclusions:
- The hybrid strategy of LAAC plus OAC is associated with improved long-term outcomes in patients experiencing CS due to OAC failure.
- This approach offers a superior alternative to OAC monotherapy for selected AF patients with recurrent stroke.
- LAAC combined with OAC demonstrates significant potential in preventing recurrent cardioembolic events.
Background:
Left atrial appendage closure (LAAC) may be used in atrial fibrillation patients with previous cardioembolic stroke (CS) despite adequate oral anticoagulation (OAC). The aim of this study was to evaluate the safety and efficacy of the hybrid strategy LAAC and OAC in patients with OAC failure.
Methods:
In this multicentre study, patients with an ascertained CS while receiving adequate OAC were divided according to the treatment strategy after the index event (LAAC vs medical therapy [MT] group). Other potential embolic sources were excluded and all patients continued OAC after the index event. The primary end point was a composite of all-cause death, CS, and major bleeding.
Results:
Among the 109 patients included in the study, 44 (40%) formed the LAAC group and 65 (60%) the MT group. At the median follow-up of 48 (interquartile range, 14) months, the LAAC group reported a lower rate of the primary end point (hazard ratio, 0.398; 95% confidence interval, 0.201-0.781; P = 0.008) and CS recurrence (hazard ratio, 0.273; 95% confidence interval, 0.060-0.852; P = 0.041). Congestive Heart Failure, Hypertension, Age (≥75 years), Diabetes, Stroke/Transient Ischemic Attack, Vascular Disease, Age (65-74 years), Sex (Female; CHA2DS2-VASc), NIH Stroke Scale (NIHSS), and acute reperfusion therapy predicted the primary end point whereas CHA2DS2-VASc and NIHSS predicted CS recurrence. Results were confirmed in a propensity score-matching analysis. The calculated annualized rate of CS was 2.0 per 100 patient-years in the LAAC group and 7.8 per 100 patient-years in the MT group.
Conclusions:
In patients with CS due to OAC failure, the hybrid strategy LAAC and OAC was associated with better long-term outcomes compared with OAC alone.
More Related Videos
07:28Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Surface Appendages of Archaea
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Oral Cavity
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
Angle Closure Glaucoma: Treatment
Bioavailability Study Design: Healthy Subjects Versus Patients